Bruker Corporation announced that Marc A. Kastner has advised the Board that he intends to retire, and he will not stand for re-election at the 2023 Annual Meeting of Stockholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
79.03 USD | +1.31% | -3.86% | +7.55% |
04-26 | Bruker Further Enhances Clinical Microbiology & Infection Diagnostics Portfolio at ESCMID Global 2024 Conference | CI |
04-22 | Bruker Agrees Signs Asset Purchase Deal With NanoString Technologies | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.55% | 11.34B | |
+8.33% | 217B | |
+6.72% | 183B | |
+10.18% | 131B | |
+24.91% | 106B | |
-0.95% | 62.16B | |
+10.56% | 51.02B | |
+4.81% | 50.89B | |
-0.24% | 40.16B | |
+1.22% | 34.79B |
- Stock Market
- Equities
- BRKR Stock
- News Bruker Corporation
- Marc A. Kastner Intends to Retire from as Director of Bruker Corporation